The device is a continuation of NovaBone’s portfolio of bioactive bone grafts. It is designed as a rapidly-absorbable binder, and the open structure of the porous component allows for rapid vascularization and mineralization.
Read the news release about NovaBone.
Related Articles on Orthopedic Devices:
TranS1 Revenues Continue to Slide in 2Q With 26% Decrease
MedShape’s Ankle Fusion Device Receives FDA 510(k) Clearance
Integra LifeSciences Launces Anterior Cervical Fixation System
